North America Insulin Pump Market 2017: Prospect, Share, Development, Growth and Demand Forecast to 2022
DUBLIN, September 4, 2017 /PRNewswire/ --
The "North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022" report has been added to Research and Markets' offering.
North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.
Long-term Growth Projection:
- Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022
- In 2016, there were more than 5,00,000 insulin pump users in United States
- Canada Insulin Pump market generated more than US$ 160 Million in 2016
- The US is the major market share holder for the North America Insulin Pump Market
Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.
North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022 provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report.
Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market.
The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.
Major Companies Covered in This Report:
- Insulet Corporation
- Medtronic
- Roche
- Animas Corporation and
- Tandem Diabetes Care
- Microport
- Sooil Development
Key Topics Covered:
1. Executive Summary
2. North America Diabetes Population (2011 - 2022) : An Analysis
3. North America Insulin Pump Market Prospect & Growth (2011 - 2022)
3.1 Insulin Pump Users
3.2 Insulin Pump Market
4. North America Insulin Pump Market Share - By Countries (2011 - 2022)
4.1 Insulin Pump Users Share
4.2 Insulin Pump Market Share
5. North America Insulin Pump Market Analysis - By Countries (2011- 2022)
5.1 United States
5.1.1 Insulin Pump Users
5.1.2 Insulin Pump Market
5.1.3 United States Insulin Pump Preferred Brand - By Product
5.1.3.1 Pediatric
5.1.3.2 Adult
5.2 Canada
5.2.1 Insulin Pump Users
5.2.2 Insulin Pump Market
5.3 Mexico
5.3.1 Insulin Pump Users
5.3.2 Insulin Pump Market
6. Key Drivers and Inhibitors of the North America Insulin Pump Market
6.1 Market Drivers
6.2 Inhibitors
7. North America Insulin Pump Market: Reimbursement & Regulation System
8. North America Insulin Pump Market - Major Deal Types
8.1 Insulin Pump Market - Collaboration Deals
8.2 Insulin Pump Market - Licensing Agreement
8.3 Insulin Pump Market - Exclusive Agreement
8.4 Insulin Pump Market - Partnerships Deals
9. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2016
9.2 Year 2015
9.3 Year 2014
9.4 Year 2013
9.5 Year 2012
10. Key Companies Analysis
10.1 Medtronic
10.1.1 Business Overview
10.1.2 Insulin Pump - Product Details
10.1.3 Medtronic - United States Diabetes Sales Analysis & Forecast (2013 - 2022)
10.1.4 Insulin Pump - Latest Development & Trends
10.2 Tandem Diabetes Care
10.2.1 Business Overview
10.2.2 Insulin Pump - Product Details
10.2.3 Tandem Diabetes Care - Insulin Pump Sales Analysis & Forecast (2013 - 2022)
10.2.4 Insulin Pump - Latest Development & Trends
10.3 Insulet Corporation
10.3.1 Business Overview
10.3.2 Insulin Pump - Product Details
10.3.3 Insulet Corporation - Insulin Pump Sales Analysis & Forecast (2011 - 2022)
10.3.4 Insulin Pump - Latest Development & Trends
10.4 Animas Corporation (Johnson & Johnson)
10.4.1 Business Overview
10.4.2 Insulin Pump - Product Details
10.4.3 Johnson & Johnson - United States Diabetes Sales Analysis & Forecast (2013 - 2022)
10.4.4 Insulin Pump - Latest Development & Trends
10.5 Roche
10.5.1 Business Overview
10.5.2 Insulin Pump - Product Details
10.5.3 Roche - North America Diabetes Sales Analysis & Forecast (2011 - 2022)
10.5.4 Insulin Pump - Latest Development & Trends
10.6 Microport
10.6.1 Business Overview
10.6.2 Insulin Pump - Product Details
10.6.3 Microport - Global Diabetes Sales Analysis & Forecast (2013 - 2022)
10.6.4 Insulin Pump - Latest Development & Trends
10.7 Sooil Development
10.7.1 Business Overview
10.7.2 Insulin Pump - Product Details
10.7.3 Insulin Pump - Latest Development & Trends
For more information about this report visit https://www.researchandmarkets.com/research/r243bn/north_america
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article